BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23171559)

  • 1. [An elderly woman with stiffness of the thumb].
    Franssen LE; Franssen MJ; Jeurissen M
    Ned Tijdschr Geneeskd; 2012; 156(47):A4550. PubMed ID: 23171559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an entity independent of scleroderma?
    Sachsenberg-Studer EM; Prins C; Saurat JH; Salomon D
    J Am Acad Dermatol; 2000 Oct; 43(4):631-4. PubMed ID: 11004618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of patients with anticentromere antibody.
    Takehara K; Soma Y; Igarashi A; Kikuchi K; Tamaki T; Ishibashi Y
    Dermatologica; 1990; 181(3):202-6. PubMed ID: 2135387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
    Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
    Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticentromere antibody and Raynaud's phenomenon.
    Czirják L; Schlammadinger J; Szegedi G
    Dermatologica; 1991; 183(1):55. PubMed ID: 1769420
    [No Abstract]   [Full Text] [Related]  

  • 6. Do the telangiectases of hereditary hemorrhagic telangiectasia and the calcinosis, Raynaud's disease, sclerodactyly, telangiectasia variant of scleroderma have a common etiology?
    Braverman IM
    Dermatology; 2006; 213(2):81-2. PubMed ID: 16902282
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorescence optical imaging as a novel technique for the visualisation of inflammation in patients with systemic sclerosis with Raynaud's phenomenon: a pilot study.
    Pfeil A; Drummer KF; Oelzner P; Böttcher J; Jung C; Wolf G
    Ann Rheum Dis; 2014 Jun; 73(6):1279-80. PubMed ID: 24532678
    [No Abstract]   [Full Text] [Related]  

  • 8. [Raynaud's phenomenon and anti-centromeric antibodies].
    Marquet R; Villar MM; Ordi J; de la Figuera M; Vilardell M
    Med Clin (Barc); 1984 Jun; 83(3):129-30. PubMed ID: 6482556
    [No Abstract]   [Full Text] [Related]  

  • 9. [The CREST syndrome associated with the sicca syndrome].
    González Perez JA; Calvo Catala J; Almela Requena JV; González-Cruz Cervellera A; Sospedra Lara EM; Hurtado Vicente MJ
    An Med Interna; 1989 Oct; 6(10):540-2. PubMed ID: 2491051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scleroderma renal crisis in a patient with anticentromere antibody-positive limited cutaneous systemic sclerosis.
    Sugimoto T; Soumura M; Danno K; Kaji K; Kondo M; Hirata K; Nakazawa J; Uzu T; Nishio Y; Kashiwagi A
    Mod Rheumatol; 2006; 16(5):309-11. PubMed ID: 17039313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study to determine whether transient receptor potential melastatin type 8 (TRPM8) antibodies are detected in scleroderma.
    Shah AA; Montagne J; Oh SY; Wigley FM; Casciola-Rosen L
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S123-6. PubMed ID: 26242276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical distribution of anticentromere antibody in Japanese patients.
    Soma Y; Takehara K; Ishibashi Y
    Dermatologica; 1989; 178(1):16-9. PubMed ID: 2645177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
    Goldman JA
    Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to diagnosis in systemic sclerosis: is sex a factor?
    Hudson M; Thombs B; Baron M;
    Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Generalized morphea-like progressive systemic sclerosis with anticentromere antibodies and eosinophilic cellulitis].
    Sasaki T; Nakajima H; Kameda Y
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):469-76. PubMed ID: 2614990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of Osler's telangiectasia and the CREST syndrome: significance of centromere antibodies].
    Stolz W; Ring J; Meurer M
    Hautarzt; 1988 Jun; 39(6):371-4. PubMed ID: 3403273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic complications of radial artery cannulation: an association with a calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia variant of scleroderma.
    Rose SH
    Anesthesiology; 1993 Mar; 78(3):587-9. PubMed ID: 8457059
    [No Abstract]   [Full Text] [Related]  

  • 20. The heterogeneity of anticentromere antibodies in immunoblotting analysis.
    Muro Y; Sugimoto K; Okazaki T; Ohashi M
    J Rheumatol; 1990 Aug; 17(8):1042-7. PubMed ID: 2213779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.